Takeda Pharma Officer Discloses Initial 193,148 Share Position
TAKEDA PHARMACEUTICAL CO LTD
Subscribe to track TAK
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Takeda Pharma Officer Discloses Initial 193,148 Share Position
Company: TAKEDA PHARMACEUTICAL CO LTD ([TAK]) Form: 3 (Initial Statement) | Filed: 2026-03-18 Significance: Low
Insider: Bitetti Teresa Marie Title: President, OBU | Relationship: Officer
Transaction Details: • Type: Initial Holdings Disclosure • Security: American Depositary Shares • Shares Owned: 193,148 • Ownership: 0.012% of Outstanding
Key Insight: New officer disclosure establishing baseline holdings. Includes 85,802 RSUs vesting through 2028.
Market Context: Routine compliance filing for company officer; does not indicate open market buying or selling.
Comprehensive Analysis
SEC Filing Analysis: TAKEDA PHARMACEUTICAL CO LTD (TAK)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Officer Teresa Bitetti establishes initial reporting position of ~193k ADS shares.
- Market Impact: Neutral; administrative filing.
Company Information
| Field | Value |
|---|---|
| Company | TAKEDA PHARMACEUTICAL CO LTD |
| Ticker Symbol | TAK |
| CIK | 0001395064 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Bitetti Teresa Marie |
| CIK | 0001977608 |
| Title/Position | President, OBU |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 3 (Initial Statement) |
| Filing Date | 2026-03-18 |
| Security Type | American Depositary Shares |
| Shares Owned | 193,148 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Shares Owned | 193,148 |
| % of Shares Outstanding | 0.012% |
| Materiality Assessment | Low |
Impact Evaluation
- Ownership Concentration: The insider holds approximately 0.012% of the 1.59 billion shares outstanding, a minor stake typical for non-executive officers.
- Transaction Significance: As a Form 3, this represents a disclosure of existing holdings rather than a new market transaction. It has no immediate impact on float or liquidity.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a routine compliance filing (Form 3) required when an individual becomes a Section 16 reporting person. It does not reflect new buying pressure or lack of confidence.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Restricted Stock: Footnotes indicate the total includes 85,802 Restricted Stock Units (RSUs) which vest in tranches between 2026 and 2028.
- Nature of Filing: Form 3s are initial statements of beneficial ownership, often filed when an executive is promoted or hired.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.